ARCHIVES

Also Von Eschenbach role in industry program raises new concerns of conflict of interest.

This article is from The Cancer Letter archive.

Vol. 31 No. 43 | November 23, 2005

Download PDF Visit The Full Archive

Related Articles

Oncologists lose money administering drugs to Medicare patients, survey finds.

January 23, 2004

Trial Data: No Benefit In Adding Perifosine to Capecitabine

June 29, 2012

Younger Patients, More Advanced Stages, More Likely To Die From Breast Cancer

September 24, 2004

Siteman Wins Core Grant; Other Cancer Center News.

August 31, 2001

Funding Opportunities: ONS Invites Applications For Instrumentation Grants on Fatigue

January 24, 1997

FDA Lacks Resources To Deal With Onslaught Of New Cancer Drugs, Friedman Tells Agency

August 14, 1992